EP1214578A1 - Verfahren zur bestimmung von analyten mittels eines spektrums im nir und angrenzenden sichtbaren spektralbereich und mittels einer anzahl von wellenlängen im längeren nir - Google Patents

Verfahren zur bestimmung von analyten mittels eines spektrums im nir und angrenzenden sichtbaren spektralbereich und mittels einer anzahl von wellenlängen im längeren nir

Info

Publication number
EP1214578A1
EP1214578A1 EP00955995A EP00955995A EP1214578A1 EP 1214578 A1 EP1214578 A1 EP 1214578A1 EP 00955995 A EP00955995 A EP 00955995A EP 00955995 A EP00955995 A EP 00955995A EP 1214578 A1 EP1214578 A1 EP 1214578A1
Authority
EP
European Patent Office
Prior art keywords
radiation
detectors
detector
sample
array
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00955995A
Other languages
English (en)
French (fr)
Inventor
Romuald Pawluczyk
Thomas Scecina
Theodore E. Cadell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CME Telemetrix Inc
Original Assignee
CME Telemetrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CME Telemetrix Inc filed Critical CME Telemetrix Inc
Publication of EP1214578A1 publication Critical patent/EP1214578A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N2021/3129Determining multicomponents by multiwavelength light
    • G01N2021/3133Determining multicomponents by multiwavelength light with selection of wavelengths before the sample
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3144Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths for oxymetry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3148Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using three or more wavelengths
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3181Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using LEDs

Definitions

  • This invention relates to a device and method for determining and monitoring concentration levels of one or more constituents within a varying in time, complex multi component structure, (for example blood constituents in blood sample, tissue or body parts) or, in particular, blood and tissue constituents in living subjects such as humans or animals.
  • MIR far infrared range
  • FIR far infrared range
  • photodetectors mainly silicon
  • AV/NIR part of visible range adjacent to NIR and part of NIR adjacent to visible
  • LWNIR longer wavelength NIR region
  • a sensor is used to externally measure either the concentration of the constituents in gases emitted by the body or contained in the perspiration, or the concentration of the constituents contained in body fluids such as tears, saliva, or urine.
  • the blood constituents are identified by measurement of attenuation of some radiation passed through a part of a patient's body such as an earlobe, a finger or skin.
  • radiation is measured at one, two or limited number of relatively narrow spectral bands obtained from separate, narrow band light sources (see for example US 4,655,225; US 4,883,953; and US 4,882,492).
  • Some of these devices perform measurements at limited number relatively narrow spectral bands consecutively selected from spectrally broad light by a set of exchangeable narrow-band spectral filters. Analysis of absolute and relative changes in light intensity at these bands under certain conditions may provide important information on body constituents. Exchange of the filters and time required for their stabilization to obtain precise measurement, very often significantly increase duration of the measurement process and as a result, the measurement in different bands are taken with significant time delays. Because of physiological variability of physical state of the alive person, this leads to situation when measurements at different wavelengths are taken under changed physical conditions of the body, making impossible to measure the constituents of the body. Another source of the error in the systems with limited number of discrete spectral bands is wavelength shift of the selected bands from measurement to the measurement and from instrument to the instrument.
  • the spectra provide information about the desired analyte as well as information about interfering substances (e.g., other analytes) and effects (e.g., light scattering).
  • the second advantage is capability to register a complete information on spectrum even if it is shifted due to temperature changes of sample.
  • the third advantage is that even if the instrument loses wavelength calibration, whole information is still preserved in the spectrum and can be easily extracted once new wavelength calibration data is available. In some cases, however, there is not enough information available in the above range or available information is insufficient for precise measurement of body constituents and additional information outside the above mentioned spectral range (usually at longer wavelengths) is required.
  • the methods that take measurements at limited number of wavelengths only within the 1100 to 1700nm region can be sufficient, because of the sharper analyte spectra that exist in this region.
  • the analyte of interest While they provide information relating to the analyte of interest, there is not enough independent information on other analytes whose absorption spectra interferes with that of the desired analyte.
  • additional information obtained in earlier mentioned spectral range 580nm to llOOnm helps to eliminate ambiguity introduced by interfering analytes. It is clear that if the sample demonstrates a temporal variability, a simultaneous measurement in whole spectral range of the interest is preferred, to eliminate possible errors caused by changes in the sample.
  • spectral measurement in limited number of points within llOOnm to 1700nm spectral range in some cases may not be sufficient for recognition of desired analyte.
  • the measurements usually are very sensitive to both: variations of spectral position of the selected points and width and shape of spectral bands measured at those points.
  • the methods when measurement in different parts of spectrum are taken at different time, or from different part of samples or within limited number of points may not be sufficient for precise analysis of constituents of the samples and more advanced instruments are required.
  • the way to eliminate these limitations and provide instrument suitable for such measurements is given it this invention.
  • previous non-invasive devices and techniques have not been sufficiently accurate to be used in place of invasive techniques in the measurement of blood constituent concentration in patients.
  • each array has its sensitivity range, which is determined by the material used to produce an array.
  • the sensitivity range determines in what spectral range the instrument built with an application of a particular array can work.
  • Grating spectrometers designed with the application of arrays of photodetectors have further intrinsic limitations, which put even stronger constrains on the performance of the instruments.
  • One such constraint is the existence of additional diffraction orders in light diffracted by a grating.
  • the existence of the second order imposes the condition that the spectral range of an array-based instrument cannot be wider than one octave, unless a special filter is placed in front of the array.
  • the present invention provides a method for monitoring the concentration level of a particular constituent in a sample or, alternatively, of measuring the concentration level of one or more different constituents using a non-invasive device with higher precision and in a short period of time, through simultaneous measurement of light signal in several different spectral ranges using separate array-based spectrometers.
  • the present inventors have determined that analyte measurement accuracy with spectral devices measuring full spectra absorption/reflectance in the AV/NIR region, is enhanced by adding to such measurement, measurements from one or more arrays of wavelength in the infrared region
  • the present invention provides a method for monitoring the concentration level of a constituent in sample comprising placing the sample in a non-invasive device capable of emitting radiation; directing the radiation onto the sample; measuring radiation collected from the sample; calculating the concentration level based on the measured radiation wherein the radiation directed onto the tissue and collected from the tissue is of the wavelengths starting at 500nm and expanding into AV/NIR range, and wavelengths in the LIR range possible from 1100 to 1700nm.
  • the present invention provides a method for measuring concentration levels of blood constituents within a living subject such as humans or animals, wherein, a polychromatic light source or other single or multiplicity of radiation sources are used that emit a broad spectrum of light in the required range.
  • a number of spectrum analyzing systems containing photodetector arrays possible sensitive in different spectral ranges provide sensitivity and resolution over portions of the range of the interest, preferably one from 500-1100nm and one from 900-1700nm and further spectral ranges.
  • the method comprises the steps of: - directing light at a continuum wavelengths (whether from one or more sources) simultaneously onto a sample or a part of a subject;
  • each part of light into a light beam suitable for simultaneous analysis of corresponding spectral content of each part, preferably by means of a dispersing element, preferable diffraction grating,
  • the arrays of the photodetectors taking measurement of dispersed light in selected part or whole AV/NIR spectral range and at least one or more arrays applied for measurements of at least selected part or whole LWNIR spectral range.
  • these measurements are taken simultaneously or sequentially, or in any combination thereof.
  • the measurement results are transferred to a microprocessor, and the concentration level of said at least one constituent of the sample, in particular of said blood or tissue is calculated and a result of each concentration level is produced.
  • a non-invasive device measuring concentration levels of constituents occurring in the sample in particular in blood and tissue in a subject such as a human or animal uses one or more radiation sources.
  • the broad spectrum of light in the adjacent visible spectrum and near infrared range provided by the radiation or light source(s) is /are powered by one or a required number of stabilized power sources .
  • the device (or devices) has a receptor shaped so that a sample or a part of the subject can be placed in contact with the receptor.
  • the receptor has means for eliminating extraneous light and is located relative to the light source (or sources) so that when a sample or body part (or tissue) is placed in contact with the receptor, the source(s) can be activated and light with continuum of wavelengths, is directed onto the part.
  • the device is equipped with means for collecting light in the AV/NIR and LWNIR spectral regions after the light has been directed onto the sample or the part. There are also means for dispersing the collected light over said broad spectrum into a dispersed spectrum of component wavelengths and means for taking measurements of a light signal at many different wavelengths in the
  • AV/NIR and LWNIR regions simultaneously or sequentially.
  • a method for determining a concentration of a constituent in a sample comprising the steps of: irradiating the sample with a continuum of wavelengths from the adjacent visible and near infrared (AV/NIR) region; collecting radiation after the radiation has been directed onto the part; dispersing the continuum of collected radiation into a dispersed spectrum of component wavelengths onto a detector, the detector taking measurements of at least one of transmitted or reflected radiation from the collected radiation; and transferring the measurements to a processor; irradiating the sample with a continuum of wavelengths in the longer wavelength near infrared (LWNIR) region; detecting one or more bands of radiation after the radiation has been directed onto the sample with a detector, the detector taking measurements of at least one of transmitted or reflected radiation ; and transferring the measurements to a processor; based on the measurements and one or more calibration algorithms, the processor calculating the concentration of said constituent in said sample, preferably one or more separate energy sources are used to provide radiation.
  • AV/NIR visible and near infrared
  • the detector of the AV/NIR is one or more spectral instruments with an array of silicon detectors and the detector of LWNIR is one or more spectral instruments with a separate array of infrared sensitive detectors for each band of radiation.
  • the detector of the AV/NIR is one or more spectral instruments with an array of silicon detectors and the detector of LWNIR is one or more spectral instruments with an array of infrared sensitive detectors and measurements for each band of radiation are taken from appropriate members of the array of infrared sensitive detectors, preferably the infrared sensitive detectors are InGaAs detectors.
  • the spectrometers with silicon detectors arrays register light in the all of the visible, visible /infrared and adjacent to visible infrared ranges within the spectral sensitivity range of the detectors, and preferably the spectrometers with infrared sensitive detectors register light in the separate infrared ranges within their spectral sensitivity range.
  • a method for determining a concentration of a constituent in a sample comprising the steps of: irradiating the sample with a continuum of wavelengths from the AV/NIR region; collecting radiation after the radiation has been directed onto the part; dispersing the continuum of collected radiation into a dispersed spectrum of component wavelengths onto a detector, the detector taking measurements of at least one of transmitted or reflected radiation from the collected radiation; and transferring the measurements to a processor; irradiating the sample with one or more bands of wavelengths in the LWNIR region; detecting the one or more bands of radiation after the radiation has been directed onto the sample with a detector, the detector taking measurements of at least one of transmitted or reflected radiation ; and transferring the measurements to a processor; based on the measurements and one or more calibration algorithms, the processor calculating the concentration of said constituent in said sample, preferably one or more separate energy sources are used to provide radiation
  • the detector of the AV/NIR is one or more spectral instruments with an array of silicon detectors and the detector of LWNIR is one or more spectral instruments with a separate array of infrared sensitive detectors for each band of radiation.
  • the detector of the AV/NIR is one or more spectral instruments with an array of silicon detectors and the detector of LWNIR is one or more spectral instruments with a separate array of infrared sensitive detectors for each band of radiation.
  • AV/NIR is one or more spectral instruments with an array of silicon detectors and the detector of LWNIR is one or more spectral instruments with an array of infrared sensitive detectors and measurements for each band of radiation are taken from appropriate members of the array of infrared sensitive detectors, preferably the infrared sensitive detectors are InGaAs detectors.
  • the spectrometers with silicon detectors arrays register light in the all of the visible, visible /infrared and adjacent to visible infrared ranges within the spectral sensitivity range of the detectors, and preferably the spectrometers with infrared sensitive detectors register light in the separate infrared ranges within their spectral sensitivity range.
  • a method for determining a concentration of a constituent in a sample comprising the steps of: irradiating the sample with a continuum of wavelengths from the AV/NIR region; collecting radiation after the radiation has been directed onto the part; dispersing the continuum of collected radiation into a dispersed spectrum of component wavelengths onto a detector, the detector taking measurements of at least one of transmitted or reflected radiation from the collected radiation; and transferring the measurements to a processor; irradiating the sample with a continuum of wavelengths from the LWNIR region; collecting radiation after the radiation has been directed onto the part; dispersing the continuum of collected radiation into a dispersed spectrum of bands of radiation onto a detector, the detector taking measurements of at least one of transmitted or reflected radiation ; and transferring the measurements to a processor; based on the measurements and one or more calibration algorithms, the processor calculating the concentration of said constituent in said sample, preferably one or more separate energy sources are used to provide radiation.
  • the detector of the AV/NIR is one or more spectral instruments with an array of silicon detectors and the detector of LWNIR is one or more spectral instruments with a separate array of infrared sensitive detectors for each band of radiation.
  • the detector of the AV/NIR is one or more spectral instruments with an array of silicon detectors and the detector of LWNIR is one or more spectral instruments with an array of infrared sensitive detectors and measurements for each band of radiation are taken from appropriate members of the array of infrared sensitive detectors, preferably the infrared sensitive detectors are InGaAs detectors.
  • the spectrometers with silicon detectors arrays register light in the all of the visible, visible /infrared and adjacent to visible infrared ranges within the spectral sensitivity range of the detectors, and preferably the spectrometers with infrared sensitive detectors register light in the separate infrared ranges within their spectral sensitivity range.
  • the sample is a finger of a subject.
  • Figure 1 shows absorbance spectra from 500-1380 nm for globulins, glucose, urea, creatine, cholesterol and human serum albumin with water displacement compensation.
  • FIG. 2 presents a general concept for simultaneous collection of spectra in a wide spectral range by many array-based instruments, each of which covers a separate spectral range.
  • concentration or “concentration level” means the amount or quantity of a constituent in a solution whether the solution is in vitro or in vivo.
  • carbohydrates means a substance, or analyte found in a tissue and includes carbohydrates such as for example glucose, bilirubin, a protein, for examples albumin or , hemoglobin.
  • tissue means any tissue of the body of a subject including for example, blood, extracellular spaces, and can mean the entire composition of a body part such as a finger or ear lobe.
  • subject means any member of the animal kingdom including, preferably, humans.
  • AV adjacent visible
  • NIR near infrared
  • MIR middle infrared radiation
  • FIR far infrared range
  • AV/NIR part of visible range adjacent to NIR and part of NIR adjacent to visible
  • LWNIR longer wavelength NIR region
  • the present inventors have determined that significant improvement of the ability to measure analytes in various samples (in tissue in particular) using a non-invasive spectral device can be achieved by adding; it is only necessary to add one or more arrays of wavelength measurements in the LWNIR or IR region to a full spectra absorption measurement in the 500 to llOOnm region to gain a significant improvement in analyte measurement accuracy.
  • analyte measurement accuracy achieved through previous methods is enhanced by adding a full spectra absorption measurement in the 1100 to 1300nm (the "First region") and/or by adding a full spectra absorption measurement in the 1590 to 1700nm (the "Second region") region to a full spectra absorption measurement in the 500 to llOOnm region, preferably in the AV/NIR region, more preferably the addition of the First region to the Second region is performed.
  • the result provides a significant improvement in analyte measurement accuracy. It will be readily appreciated that the method includes addition of measurements of full spectra absorption from other regions or whole range in the LWNIR or IR.
  • the AV/NIR range has been used because, among other reasons, silicon detectors are sensitive in that range. Silicon detectors, particularly silicon-based detector arrays provide superior noise and dynamic range performance, are readily available, and, are relatively inexpensive. However, the 900 to 1700nm and further IR wavelength ranges provide sharper spectra for many of the analytes of interest as may be seen by referring to Figure 1.
  • InGaAs detector may be used to measure spectra in this region while other detectors array can cover further IR ranges. Unfortunately, these detectors provide inferior noise and dynamic range performance in comparison with silicon, consequently the lower signal to noise ratio offsets some of the advantage of the sharper spectra.
  • one or more arrays of spectra are added to measurements in the AV/ NIR region.
  • the results are significantly better than those achieve with measurements of spectra in either range separately.
  • the light is delivered to the sample or to the tissue, such as a finger, by a suitable conduit such as fiber optics bundle.
  • the light emerging from the finger is collected and delivered to separate sets of detectors by another conduit such as another fiber optics bundle.
  • a silicon diode array is used to detect light in the AV/NIR region and an InGaAs photodiode array can be used to detect light in the LWNIR region and other detector arrays in further IR ranges.
  • light all refer to the light energy provided by a source which is capable of delivering sufficient radiation of a desired wavelength. Any device which is capable of delivering radiation in the ranges of the invention may be utilized and are within the scope of the present invention.
  • the light source can emit light over a very wide band-width including light in adjacent to infrared visible and the near infrared spectrum.
  • the light from the light source is delivered by any optical means to the sample, which preferably is placed in an appropriate receptor.
  • the light may pass first through a collimator (a collection of lenses that concentrate the light into a narrow parallel beam directed at the receptor).
  • the light in the form of a wide divergent light beam, is delivered by a fiber-optics means directly to a sample or to a receptor containing the sample.
  • An appropriate receptor is shaped to receive a measured sample.
  • samples may be, for example, a part of subject being measured, for example, a finger or arm of a human.
  • An appropriate receptor may also be a sample holder in a form of any transparent container or, for some applications, in a form of calibrated cuvette with parallel walls.
  • a receptor could be shaped so that the part of the human or animal, onto which the light is to be directed, is placed near the receptor rather than within the receptor.
  • an integrating cavity may play the role of sample receptor with light coupled into the cavity either directly or by any optical means including optical fibers.
  • the light is collected by any optical means.
  • the light from the sample can be light that has passed through the sample (body part or tissue, for example) or has reflected off it , or a combination thereof.
  • the collected light is light that has passed through the sample.
  • each light beam may be optionally shaped to a narrow light source by means of suitably distributed fibers or a set of optical elements and a slit.
  • the light from a narrow light source can be either collimated or directly delivered to a diffraction means.
  • Radiation from a sample interacts with a dispersion means, such as a grating, which disperses the radiation into its component wavelengths so that the light in the AV/NIR region falls along detectors, preferably a length of linear array of silicon of detectors such that light from the LWNIR and other IR regions falls onto the array of detectors, preferably InGaAs detectors.
  • a dispersion means such as a grating
  • detectors preferably a length of linear array of silicon of detectors such that light from the LWNIR and other IR regions falls onto the array of detectors, preferably InGaAs detectors.
  • these arrays are comprised of individual detectors and are sensitive in a range of wavelengths which correspond to the AV and IR regions.
  • all detectors are electronically simultaneously scanned to measure signal registered by each individual unit.
  • the results from the detector are directed to a microprocessor for analysis of the measurements from the detectors and ultimately produces a concentration result for each constituent by applying one of many known chemometric methods such as form example PLS or
  • PCR results can be shown on a display and/or printed on a printer.
  • a keyboard allows a user to control the device, for example, to specify a particular constituent to be measured.
  • the timing and control may be activated by the microprocessor to control the device, for example, to determine number and timing of measurements.
  • the light source or sources can be a quartz-halogen or a tungsten-halogen bulb, supported by any other light source such as a laser or light emitting diodes (LED) (or other light sources able to emit radiation in the required ranges of AV and IR). Any such source is (or are) powered by a stabilized power source, for example, a DC power supply, or by a battery.
  • a stabilized power source for example, a DC power supply, or by a battery.
  • each linear array detector has a sufficient number of photosensitive elements to cover a required spectral range to provide adequate spectral resolution.
  • a standard measurement procedure comprises taking reference measurements of incident light (being the light generated in the device when no part of the subject is in contact with the receptor) and taking measurements while the sample is present in the receptor. The negative logarithm of the ratio of sample measurement to reference measurements is then calculated and compared to reference measurements.
  • the second derivative of measurements may be taken in order to reduce any variation in the result that will be caused by a change in path length for the light.
  • the noise level within the device may be reduced by a multiple scanning technique whereby the detectors take a number of measurements and then average the results.
  • the linear array detector and IR detectors are scanned many times for several repetitions and then the results averaged.
  • the device and method can be used to measure concentration levels of various other constituents found within the blood of humans and animals, for example, amino acids, nitrogen, blood oxygenation, carbon dioxide, cortisol, creatine, creatinine, glucose, ketones, lipids, fat, urea, amino acids, fatty acids, glycosylated hemoglobin, cholesterol, alcohol, lactate, Ca++, K+, Cl-m HC03- and HP04-, to name a few.
  • the method and device can be modified to measure several constituents simultaneously, finally it can be also modified to measure chemical composition of any other materials or samples whose properties may vary in time, demonstrating specific spectral features in AV and IR ranges.
  • the following is a non-limiting exemplary embodiment of the present invention.
  • a certain number (nl) of light sources 21 generate a broad spectrum of light covering all required spectral ranges.
  • the light sources contain power supplies, light sources, means to collect light from these sources and means to concentrate light into optical elements predestined to mix light from these sources and bring it to the sample.
  • Light from the light source is collected by light collecting means, preferably by multiple fiber bundles 22, and is optionally delivered through a light mixing device 23 (glass rod, for example) and, optionally a light forming device 24 (light collimator, or focusing lens, for example) to a sample receptor 25 (sample holder, finger holder, integrating cavity or any other device to hold sample) containing a sample 26 (human finger, for example).
  • a light collecting device 27 another light bundle, or any other light collecting optical system, lens, for example
  • Division can be performed either by simple splitting of fibers into multiplicity of fiber optics legs or using wide-band or dichroic beam splitters.
  • Each "part" of light is directed to separate spectrum analyzing devices 28, preferably array-based spectrometers.
  • the number (n2) of spectrometers (generally different from the number of light sources) is selected to cover an entire spectral range of interest for a tested sample with demanded resolution.
  • the light delivering means together with the spectrum analyzing device may optionally contain a light beam forming optical system, specific for a given spectrum analyzing device, spectrum specific dispersing or light filtering element, a light beam forming system for dispersed light and a wavelength specific array of the photodetectors.
  • the signal from each array is read by one or more specialized electronics boards (29), usually specific for each kind of array or detector, and in addition to collection of the signal, performs control of the array by providing proper electrical signals.
EP00955995A 1999-08-31 2000-08-31 Verfahren zur bestimmung von analyten mittels eines spektrums im nir und angrenzenden sichtbaren spektralbereich und mittels einer anzahl von wellenlängen im längeren nir Withdrawn EP1214578A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15168599P 1999-08-31 1999-08-31
US151685P 1999-08-31
PCT/CA2000/001003 WO2001016578A1 (en) 1999-08-31 2000-08-31 Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths

Publications (1)

Publication Number Publication Date
EP1214578A1 true EP1214578A1 (de) 2002-06-19

Family

ID=22539830

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00955995A Withdrawn EP1214578A1 (de) 1999-08-31 2000-08-31 Verfahren zur bestimmung von analyten mittels eines spektrums im nir und angrenzenden sichtbaren spektralbereich und mittels einer anzahl von wellenlängen im längeren nir

Country Status (4)

Country Link
EP (1) EP1214578A1 (de)
JP (1) JP2003508745A (de)
CA (1) CA2383727A1 (de)
WO (1) WO2001016578A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
JP4054853B2 (ja) * 2000-10-17 2008-03-05 独立行政法人農業・食品産業技術総合研究機構 近赤外分光法を用いた血液分析法
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
AU2002312521A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
WO2002100461A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
AU2002337086A1 (en) * 2001-09-12 2003-03-24 Tecan Trading Ag Optical device, system and use thereof
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US6960769B2 (en) 2002-10-03 2005-11-01 Abb Inc. Infrared measuring apparatus and method for on-line application in manufacturing processes
WO2004041082A1 (en) 2002-11-01 2004-05-21 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling
EP1578286A4 (de) * 2002-12-13 2009-01-14 Pelikan Technologies Inc Verfahren und vorrichtung zum messen von analyten
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US20060234386A1 (en) * 2003-04-30 2006-10-19 Mcgill University Method and system for measuring lactate levels in vivo
DE602004028463D1 (de) 2003-05-30 2010-09-16 Pelikan Technologies Inc Verfahren und vorrichtung zur injektion von flüssigkeit
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US20060097173A1 (en) 2003-10-15 2006-05-11 Sanofi-Aventis Deutschland Method and device for the quantitative analysis of solutions and dispersions by means of near infrared spectroscopy
DE10326152A1 (de) * 2003-06-06 2005-01-05 Aventis Pharma Deutschland Gmbh Verfahren und Vorrichtung zur quantitativen Analyse von Lösungen und Dispersionen mittels Nahinfrarot-Spektroskopie
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (de) 2003-10-14 2009-01-21 Pelikan Technologies Inc Verfahren und gerät für eine variable anwenderschnittstelle
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (de) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Verfahren und vorrichtung zur verbesserung der fluidströmung und der probennahme
US7301164B2 (en) * 2004-01-30 2007-11-27 Abb Inc. Measuring apparatus
EP1751546A2 (de) 2004-05-20 2007-02-14 Albatros Technologies GmbH & Co. KG Bedruckbares wassergel für biosensoren
EP1765194A4 (de) 2004-06-03 2010-09-29 Pelikan Technologies Inc Verfahren und gerät für eine flüssigkeitsentnahmenvorrichtung
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
CA2700996C (en) * 2007-10-04 2016-12-13 The Curators Of The University Of Missouri Optical device components
BRPI0909825B8 (pt) 2008-03-25 2021-06-22 Univ Missouri método e sistemas para detecção não-invasiva de glicose sanguíneo utilizando dados espectrais de um ou mais componentes que não a glicose
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
CN102083360B (zh) 2008-05-22 2015-04-15 密苏里大学董事会 用光谱数据分析进行无创的光学血糖检测的方法和系统
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
AU2015271892B2 (en) * 2011-04-06 2018-03-15 Klein Medical Limited Spectroscopic analyser
JP6057387B2 (ja) 2011-04-06 2017-01-11 クライン メディカル リミテッド 分光分析器
CN110672550B (zh) * 2019-09-10 2021-11-19 中国科学院上海技术物理研究所 一种微区重要生物资源像谱分析仪

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5361758A (en) * 1988-06-09 1994-11-08 Cme Telemetrix Inc. Method and device for measuring concentration levels of blood constituents non-invasively
US5818048A (en) * 1992-07-15 1998-10-06 Optix Lp Rapid non-invasive optical analysis using broad bandpass spectral processing
HU216847B (hu) * 1995-05-23 1999-12-28 Gyula Domján Eljárás és berendezés vérösszetétel-paraméterek gyors noninvazív meghatározására
US5743262A (en) * 1995-06-07 1998-04-28 Masimo Corporation Blood glucose monitoring system
US5747806A (en) * 1996-02-02 1998-05-05 Instrumentation Metrics, Inc Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0116578A1 *

Also Published As

Publication number Publication date
JP2003508745A (ja) 2003-03-04
WO2001016578A1 (en) 2001-03-08
CA2383727A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
US6741875B1 (en) Method for determination of analytes using near infrared, adjacent visible spectrum and an array of longer near infrared wavelengths
EP1214578A1 (de) Verfahren zur bestimmung von analyten mittels eines spektrums im nir und angrenzenden sichtbaren spektralbereich und mittels einer anzahl von wellenlängen im längeren nir
US6741876B1 (en) Method for determination of analytes using NIR, adjacent visible spectrum and discrete NIR wavelenths
JP5982364B2 (ja) 測定媒体の成分または特性、特に生理的血液値を特定およびモニタするための装置ならびに方法
US5379764A (en) Non-invasive determination of analyte concentration in body of mammals
AU2001263290B2 (en) Dual beam ftir methods and devices for analyte detection in samples of low transmissivity
KR100314296B1 (ko) 대상물의농도및광학적특성의비-분광광도측정장치및방법
JP3249517B2 (ja) 血液もしくは組織の各種成分の濃度を決定するための非侵襲性装置並びに方法
US7343185B2 (en) Measurement of body compounds
US5372135A (en) Blood constituent determination based on differential spectral analysis
US6990364B2 (en) Noninvasive measurement of glucose through the optical properties of tissue
US8406839B2 (en) Method and apparatus for determining blood analytes
EP1214577A1 (de) Verfahren zur bestimmung von analyten mittels eines spektrums im nir und angrenzenden sichtbaren spektralbereich und mittels diskreter wellenlängen im nir
JP2002236097A (ja) 非侵襲性近赤外分光法における多重スペクトル分析のための方法および装置
AU2001263290A1 (en) Dual beam ftir methods and devices for analyte detection in samples of low transmissivity
JP2010066280A (ja) グルコース濃度の定量装置
AU2002249985A1 (en) Noninvasive measurement of glucose through the optical properties of tissue
JP4472794B2 (ja) グルコース濃度の定量装置
US6615151B1 (en) Method for creating spectral instrument variation tolerance in calibration algorithms
TR202013687A2 (tr) Girişimsiz Mobil Kan Şekeri Ölçüm Cihazı
Yoon et al. Optical measurement of glucose levels in scattering media

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020213

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060425